226950.KQ | OliX Pharmaceuticals,Inc Annual & Quarterly

Annual Balance Sheets

(In KRW)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	102.82 Billion	132.65 Billion	86.67 Billion	78.57 Billion	45.2 Billion	55.63 Billion
Total Current Assets	32.14 Billion	65.04 Billion	52.23 Billion	69.04 Billion	37.43 Billion	48.69 Billion
Cash And Short Term Investments	25.92 Billion	61.87 Billion	49.75 Billion	68.11 Billion	35.54 Billion	47.05 Billion
Cash and Cash Equivalents	11.98 Billion	4.93 Billion	34.33 Billion	11.32 Billion	4.95 Billion	2.81 Billion
Short Term Investments	13.94 Billion	56.94 Billion	15.42 Billion	56.78 Billion	30.58 Billion	44.24 Billion
Net Receivables	5.28 Billion	1.14 Billion	551.87 Million	518.44 Million	541.04 Million	287.22 Million
Inventory	468.4 Million	657.17 Million	374.12 Million	304.17 Million	365.82 Million	634.83 Million
Other Current Assets	465.72 Million	1.36 Billion	1.55 Billion	113.51 Million	992.44 Million	719.24 Million
Total Non-Current Assets	70.68 Billion	67.6 Billion	34.43 Billion	9.53 Billion	7.76 Billion	6.93 Billion
Net PPE	43.9 Billion	37.23 Billion	31.52 Billion	6.18 Billion	5.91 Billion	5.22 Billion
Good Will And Intangible Assets	1.98 Billion	2.1 Billion	2.13 Billion	2.52 Billion	1.41 Billion	1.33 Billion
Good Will	-	-	-	-	-	-
Intangible Assets	1.98 Billion	2.1 Billion	2.13 Billion	2.52 Billion	1.41 Billion	1.33 Billion
Long-Term Investments	23.48 Billion	26.8 Billion	500.87 Thousand	455.04 Thousand	20.00	160.00
Tax Assets	4.00	4.00	5.00	-1.00	-20.00	-165.00
Other Non Current Assets	1.31 Billion	1.45 Billion	772.04 Million	820.52 Million	445.69 Million	378.98 Million
Other Assets	-	-	-	-	-	1.00
Total Liabilities	52.48 Billion	66.44 Billion	67.26 Billion	33.22 Billion	3.39 Billion	698.93 Million
Total Current Liabilities	6.56 Billion	39.54 Billion	40.36 Billion	4.48 Billion	2.75 Billion	314.09 Million
Account Payables	-	-	-	2.00	-	267.15 Million
Tax Payables	-	-	-	-	-	-
Short Term Debt	1.06 Billion	20.17 Billion	16.89 Billion	258.62 Million	15.67 Million	-
Deferred Revenue	2.95 Billion	6.28 Billion	10.5 Billion	3.47 Billion	1.45 Billion	-
Other Current Liabilities	2.53 Billion	13.09 Billion	12.96 Billion	752.27 Million	1.28 Billion	46.93 Million
Total Non Current Liabilities	45.92 Billion	26.9 Billion	26.89 Billion	28.73 Billion	645.47 Million	384.84 Million
Long-Term Debt	35.36 Billion	20 Billion	20.32 Billion	14.01 Billion	206.93 Million	-
Deferred Revenue Non Current	2.61 Billion	2.83 Billion	6.06 Billion	9.04 Billion	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	5.01 Billion	248.69 Million	452.02 Million	4.03 Billion	438.53 Million	384.84 Million
Other Liabilities	-	1.00	-	-	1.00	-
Total Equity	50.33 Billion	66.2 Billion	19.4 Billion	45.35 Billion	41.8 Billion	54.93 Billion
Stock Holders Equity	49.85 Billion	65.9 Billion	18.52 Billion	45.28 Billion	41.79 Billion	54.93 Billion
Common Stock	8 Billion	8.35 Billion	6.85 Billion	6.77 Billion	3.26 Billion	3.25 Billion
Retained Earnings	-122.1 Billion	-103 Billion	-83.51 Billion	-53.79 Billion	-34.41 Billion	-20.05 Billion
Accumulated other comprehensive income	21.17 Billion	18.69 Billion	12.3 Billion	11.21 Billion	1.4 Billion	576.08 Million
Common Stock Equity	49.85 Billion	65.9 Billion	18.52 Billion	45.28 Billion	41.79 Billion	54.93 Billion
Capital Lease Obligation	2.93 Billion	3.82 Billion	51.68 Million	257 Million	206.93 Million	-
Total Investments	37.42 Billion	83.75 Billion	15.42 Billion	56.78 Billion	30.58 Billion	44.24 Billion
Total Debt	39.35 Billion	43.99 Billion	37.27 Billion	14.52 Billion	222.61 Million	-
Net Debt	27.37 Billion	39.06 Billion	2.93 Billion	3.19 Billion	-4.73 Billion	-2.81 Billion

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Total Assets	92.5 Billion	101.87 Billion	102.82 Billion	102.82 Billion	101.88 Billion	108.4 Billion
Total Current Assets	28.29 Billion	41.11 Billion	32.14 Billion	32.14 Billion	34.96 Billion	46.17 Billion
Cash And Short Term Investments	24.44 Billion	37.92 Billion	25.92 Billion	25.92 Billion	31.37 Billion	42.31 Billion
Cash and Cash Equivalents	6.09 Billion	31.65 Billion	11.98 Billion	11.98 Billion	7.02 Billion	6.68 Billion
Short Term Investments	18.35 Billion	6.26 Billion	13.94 Billion	13.94 Billion	24.34 Billion	35.62 Billion
Net Receivables	2.55 Billion	1.81 Billion	5.28 Billion	5.28 Billion	1.93 Billion	2.09 Billion
Inventory	793.09 Million	773 Million	468.4 Million	468.4 Million	697.36 Million	680.76 Million
Other Current Assets	507.92 Million	612.63 Million	465.72 Million	465.72 Million	957.74 Million	1.08 Billion
Total Non-Current Assets	64.2 Billion	60.75 Billion	70.68 Billion	70.68 Billion	66.91 Billion	62.22 Billion
Net PPE	48.1 Billion	43.1 Billion	43.9 Billion	43.9 Billion	42.15 Billion	41.22 Billion
Good Will And Intangible Assets	1.78 Billion	1.82 Billion	1.98 Billion	1.98 Billion	1.99 Billion	2.04 Billion
Good Will	-	-	-	-	-	-
Intangible Assets	1.78 Billion	1.82 Billion	1.98 Billion	1.98 Billion	1.99 Billion	2.04 Billion
Long-Term Investments	12.4 Billion	14.48 Billion	23.48 Billion	23.48 Billion	21.25 Billion	17.33 Billion
Tax Assets	-5.00	1.00	4.00	4.00	1.00	4.00
Other Non Current Assets	1.9 Billion	1.33 Billion	1.31 Billion	1.31 Billion	1.5 Billion	1.61 Billion
Other Assets	-	-	-	-	-	-
Total Liabilities	66.1 Billion	64.89 Billion	52.48 Billion	52.48 Billion	60.61 Billion	65.83 Billion
Total Current Liabilities	31.26 Billion	7.08 Billion	6.56 Billion	6.56 Billion	36.38 Billion	40.2 Billion
Account Payables	-	-	-	-	-	1.00
Tax Payables	-	-	-	-	-	-
Short Term Debt	19.38 Billion	1.8 Billion	1.06 Billion	1.06 Billion	20.98 Billion	21.46 Billion
Deferred Revenue	314.35 Million	2.45 Billion	2.95 Billion	2.95 Billion	5.5 Billion	6.49 Billion
Other Current Liabilities	11.57 Billion	2.82 Billion	2.53 Billion	2.53 Billion	9.89 Billion	12.25 Billion
Total Non Current Liabilities	34.83 Billion	57.8 Billion	45.92 Billion	45.92 Billion	24.22 Billion	25.62 Billion
Long-Term Debt	25.75 Billion	42.22 Billion	35.36 Billion	35.36 Billion	20 Billion	20 Billion
Deferred Revenue Non Current	-	2.35 Billion	2.61 Billion	2.61 Billion	602.44 Million	1.34 Billion
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	9.08 Billion	10.43 Billion	5.01 Billion	5.01 Billion	289.97 Million	280.86 Million
Other Liabilities	-	-	-	-	1.00	-
Total Equity	26.39 Billion	36.97 Billion	50.33 Billion	50.33 Billion	41.27 Billion	42.57 Billion
Stock Holders Equity	25.83 Billion	36.45 Billion	49.85 Billion	49.85 Billion	40.83 Billion	42.18 Billion
Common Stock	8.31 Billion	8.26 Billion	8 Billion	8 Billion	8 Billion	6.86 Billion
Retained Earnings	-140.09 Billion	-130.51 Billion	-122.1 Billion	-122.1 Billion	-125.3 Billion	-120.37 Billion
Accumulated other comprehensive income	15.14 Billion	16.18 Billion	21.17 Billion	21.17 Billion	15.42 Billion	11.84 Billion
Common Stock Equity	25.83 Billion	36.45 Billion	49.85 Billion	49.85 Billion	40.83 Billion	42.18 Billion
Capital Lease Obligation	2.61 Billion	2.79 Billion	2.93 Billion	2.93 Billion	3.33 Billion	4 Billion
Total Investments	30.76 Billion	20.74 Billion	37.42 Billion	37.42 Billion	45.59 Billion	52.96 Billion
Total Debt	47.74 Billion	46.82 Billion	39.35 Billion	39.35 Billion	44.31 Billion	45.46 Billion
Net Debt	41.65 Billion	15.17 Billion	27.37 Billion	27.37 Billion	37.29 Billion	38.77 Billion

Balance Sheet Charts

J D Wetherspoon plc

JDW

Full Analysis

Annual Balance Sheets
Shinelong Automotive Lightweight Application Limited

1930

Full Analysis

Annual Balance Sheets
NEOWIZ

095660

Full Analysis

Annual Balance Sheets
EXEL Industries SA

EXE

Full Analysis

Annual Balance Sheets
Monarca Minerals Inc.

ORAGF

Full Analysis

Annual Balance Sheets
Hampidjan Hf.

HAMP

Full Analysis

Annual Balance Sheets

Global Stocks Search

OliX Pharmaceuticals,Inc (226950.KQ)

Annual Balance Sheets

Balance Sheet Charts

J D Wetherspoon plc

Shinelong Automotive Lightweight Application Limited

NEOWIZ

EXEL Industries SA

Monarca Minerals Inc.

Hampidjan Hf.